Adviser Investments LLC Charles River Laboratories International, Inc. Transaction History

Adviser Investments LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 11, 2023	BUY	$194.44 - $217.61 $316,937 - $354,704	1,630 New	1,630 $319,000
Q1 2022 May 04, 2022	SELL	$255.51 - $362.11 $4,599 - $6,517	-18 Reduced 1.25%	1,422 $404,000
Q4 2021 Jan 31, 2022	BUY	$351.38 - $448.68 $6,324 - $8,076	18 Added 1.27%	1,440 $543,000
Q2 2020 Aug 03, 2020	BUY	$118.84 - $189.72 $168,990 - $269,781	1,422 New	1,422 $248,000
Q1 2020 Apr 08, 2020	SELL	$98.9 - $178.34 $140,635 - $253,599	-1,422 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$126.05 - $152.76 $179,243 - $217,224	1,422 New	1,422 $217,000
Q3 2019 Nov 13, 2019	SELL	$125.07 - $143.67 $177,849 - $204,298	-1,422 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$104.82 - $146.73 $149,054 - $208,650	1,422 New	1,422 $207,000
Q3 2018 Nov 14, 2018	SELL	$112.11 - $134.54 $159,420 - $191,315	-1,422 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$98.19 - $115.2 $139,626 - $163,814	1,422 New	1,422 $152,000

696

51.8M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.33B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Adviser Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Adviser Investments LLC with notifications on news.